Blood clots during COVID-19 may be a cause of ongoing cognitive problems

By SWA

Blood clots during COVID-19 may be a cause of ongoing cognitive problems September 02, 2023 High D-dimer is causing thrombosis and why not in the brain blocking the hypothalamic systems from delivering the needed hormones? 

 I have been saying this for over 2 years.  

 "High levels of two proteins at the time of COVID-19 have been found in patients who later experienced cognitive problems, including ‘brain fog’, giving a major clue as to one cause of their symptoms: blood clots."
read: https://www.ox.ac.uk/news/2023-09-01-blood-clots-during-covid-19-may-be-cause-ongoing-cognitive-problems 

and: Blood Clues to Long-COVID Brain Fog Discovered https://neurosciencenews.com/brainfog-covid-blood-23859/

We are stuck with the question, how can clots be removed from the brain?
Will Heparin reach the clots in de brain without producing damage? 

Can Heparin breach BBB?

Heparin is a medication commonly used as an anticoagulant, primarily to prevent and treat blood clots in the body. The blood-brain barrier (BBB) is a highly selective membrane that separates the circulating blood from the brain and central nervous system (CNS). Its primary function is to protect the brain from potentially harmful substances in the bloodstream.

Heparin is a large molecule that does not readily cross the BBB under normal circumstances. The BBB is designed to prevent many large molecules, including most drugs and therapeutic agents, from entering the brain and affecting its function. However, in certain medical situations or under specific conditions, heparin may potentially breach the BBB to some extent.

For example, in some cases of traumatic brain injury or neurosurgery, the BBB may become compromised, allowing larger molecules like heparin to enter the brain more easily. Additionally, researchers have been exploring methods to modify heparin or use other delivery systems to enhance its ability to cross the BBB for specific therapeutic purposes, such as treating certain neurological disorders. These approaches are still in the experimental stages and are not part of standard clinical practice.


Comments

Post a Comment

Popular posts from this blog

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By SWA
Image
Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially presenting as petechiae, diagnosed by a rheumatologist. However, following the second dose, symptoms rapidly escalated, resulting in intense burning pain and thinning of the skin. The skin on the legs and thighs became paper-thin and could tear with the slightest touch, with the affected area e...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By SWA
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By SWA
Image
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. In 2008, while investigating permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II. However, surgery in 2009 brought no improvement. In 2010, a DNA test showed a genetic marker in the ACTN3 gene: https://www.malacards.org/search/results?q=ACTN3%20gene%20and%20Spinal%20Muscular%20Atrophy%20(SMA) A 2015 MRI revealed ankylosing spondylitis, multiple Tarlov cysts, stenosis at L4 and L5, spinal canal narrowing, and widespread degenerative changes. Surgery on L4 and L5 ...
Read more